The yellow fever vaccine global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Yellow Fever Vaccine Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The yellow fever vaccine market size has grown strongly in recent years. It will grow from $4.32 billion in 2023 to $4.54 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology.
The yellow fever vaccine market size is expected to see strong growth in the next few years. It will grow to $5.56 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
Scope Of Yellow Fever Vaccine Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Yellow Fever Vaccine Market Overview
Market Drivers –
Increasing international travel is expected to propel the growth of the yellow fever vaccine market going forward. International travel refers to the movement of individuals across country borders for purposes such as tourism, business, or personal reasons. International travel is rising due to increased global connectivity, economic growth, and the relaxation of travel restrictions post-pandemic. The yellow fever vaccine is required or recommended for travelers visiting regions where yellow fever is endemic to prevent infection and comply with international health regulations. For instance, in January 2024, according to the World Tourism Organization, a Spain-based agency, in 2023, there were 1.286 billion international tourists (overnight visitors) globally, while in 2022, there were 960 million international tourists (overnight visitors). This shows an increase of 326 million international tourists from 2022 to 2023. Therefore, increasing international travel is driving the growth of the yellow fever vaccine market.
Market Trends –
Major companies operating in the yellow fever vaccine market are focusing on developing effective next-generation yellow fever vaccines, such as the T-cell adaptive booster vaccine, to meet an increasing global vaccine demand. A T-cell adaptive booster vaccine is a type of vaccine designed to enhance the immune system’s memory T-cell response, providing prolonged and robust immunity against specific pathogens. For instance, in April 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization that provides reference microorganisms, cell lines, and other materials for research and development, to introduce CD8+ T-cell adaptive vaccines. These vaccines are specifically designed for yellow fever and aim to stimulate a potent cytotoxic T-cell response, which is essential for identifying and eliminating virus-infected cells. By promoting the production of memory CD8+ T-cells, these vaccines provide long-lasting and robust immunity. They focus on the cellular immune response rather than just antibody production, thus offering comprehensive protection against yellow fever and potentially enhancing effectiveness in individuals with different immune profiles.
The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
Get an inside scoop of the yellow fever vaccine market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp
Regional Insights –
North America was the largest region in the yellow fever vaccine market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.
Table of Contents
1. Executive Summary
2. Yellow Fever Vaccine Market characterstics
3. Yellow Fever Vaccine Market Trends And Strategies
4. Yellow Fever Vaccine Market – Macro Economic Scenario
5. Global Yellow Fever Vaccine Market Size And Growth
…..
32. Global Yellow Fever Vaccine Market Competitive Benchmarking
33. Global Yellow Fever Vaccine Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Yellow Fever Vaccine Market
35. Yellow Fever Vaccine Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model”
